Table 2.
Preliminary National Central-Line–Associated Bloodstream Infection (CLABSI) Standardized Infection Ratios (SIRs) During the Early Months of the COVID-19 Pandemic, by Location Type, April 2020–June 2020
| Location Type | No. of Locations | Observed CLABSI | Predicted CLABSI | Central-Line Days | 2020 Q2 SIR | 2019 Q2 SIR | SIR % Changea | 95% Confidence Interval for the SIR % Change | Location Type distribution of the Standardized Infection Ratio (SIR) for 2020 Q2b | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10% | 25% | 50% | 75% | 90% | 100% | |||||||||
| Critical care locations | ||||||||||||||
| Burn critical care | 51 | 29 | 52.58 | 15,819 | 0.55c | 0.44c | 25.3 | (−28.1 to 120.6) | 0.00 | 0.00 | 0.10 | 0.96 | 1.42 | 2.44 |
| Medical cardiac critical care | 211 | 91 | 87.17 | 81,439 | 1.04 | 1.06 | −1.1 | (−26.0 to 32.3) | … | … | … | … | … | … |
| Surgical cardiothoracic critical care | 341 | 116 | 193.66 | 180,522 | 0.60c | 0.64c | −6.3 | (−26.9 to 20.0) | 0.00 | 0.00 | 0.57 | 0.96 | 1.60 | 2.92 |
| Pediatric surgical cardiothoracic critical care | 44 | 40 | 68.48 | 43,248 | 0.58c | 0.50c | 16.0 | (−26.7 to 84.20) | 0.00 | 0.00 | 0.51 | 0.88 | 1.25 | 2.10 |
| Medical critical care | 584 | 397 | 274.19 | 263,176 | 1.45c | 0.91 | 59.6d | (35.9 to 87.7) | 0.00 | 0.00 | 1.21 | 2.35 | 2.78 | 7.39 |
| Medical-surgical critical care | 2,076 | 885 | 727.37 | 774,905 | 1.22c | 0.77c | 58.9d | (42.6 to 77.3) | 0.00 | 0.00 | 0.93 | 1.80 | 3.35 | 5.21 |
| Pediatric medical-surgical critical care | 237 | 76 | 106.36 | 70,845 | 0.71c | 0.66c | 8.3 | (−20.8 to 47.7) | 0.00 | 0.19 | 0.78 | 1.06 | 1.87 | 2.96 |
| Pediatric medical critical care | 27 | 8 | 5.73 | 3,944 | 1.40 | 1.50 | −6.9 | (−66.3 to 156.8) | … | … | … | … | … | … |
| Neurologic critical care | 73 | 21 | 28.58 | 26,628 | 0.73 | 0.73 | 0.4 | (−46.4 to 88.7) | … | … | … | … | … | … |
| Neurosurgical critical care | 157 | 62 | 67.29 | 61,448 | 0.92 | 0.44c | 107.9d | (34.5 to 226.8) | … | … | … | … | … | … |
| Surgical critical care | 260 | 136 | 135.29 | 125,839 | 1.01 | 0.93 | 8.6 | (−14.8 to 38.3) | 0.00 | 0.00 | 0.81 | 1.20 | 1.96 | 3.56 |
| Trauma critical care | 126 | 48 | 85.99 | 57,473 | 0.56c | 0.56c | −0.5 | (33.2 to 48.1) | 0.00 | 0.00 | 0.35 | 0.93 | 1.74 | 2.84 |
| NICU | ||||||||||||||
| Neonatal critical care (level II/III) | 514 | 68 | 118.07 | 84,535 | 0.58c | 0.66c | −13.0 | (−37.1 to 20.0) | 0.00 | 0.00 | 0.00 | 0.94 | 1.45 | 2.56 |
| Neonatal critical care (level III) | 330 | 94 | 187.39 | 134,080 | 0.50c | 0.63c | −20.9 | (−39.6 to 3.3) | 0.00 | 0.00 | 0.00 | 0.80 | 1.13 | 1.96 |
| Wards | ||||||||||||||
| Medical ward | 2134 | 251 | 381.28 | 435,198 | 0.66c | 0.64c | 2.8 | (−13.1 to 21.4) | … | … | … | … | … | … |
| Medical-surgical ward | 3,985 | 346 | 512.83 | 619,386 | 0.67c | 0.59c | 14.3 | (−1.3 to 32.5) | … | … | … | … | … | … |
| Pediatric medical-surgical ward | 564 | 49 | 54.65 | 53,821 | 0.90 | 0.41c | 117.6d | (37.1 to 249.5) | … | … | … | … | … | … |
| Pediatric medical ward | 180 | 19 | 22.89 | 21,839 | 0.83 | 0.75 | 10.2 | (−40.4 to 101.9) | … | … | … | … | … | … |
| Surgical ward | 1,168 | 134 | 202.84 | 228,044 | 0.66c | 0.60c | 10.6 | (−12.6 to 40.1) | … | … | … | … | … | … |
| Pediatric surgical ward | 30 | 5 | 6.80 | 6,234 | 0.74 | 0.76 | −3.4 | (−71.3 to 198.5) | … | … | … | … | … | … |
Note. NICU, neonatal intensive care units.
a
Calculated as follows: [(SIR for 2020 Q2 – SIR for 2019 Q2)/SIR for 2019 Q2 × 100].
b
If there were <20 SIRs nationally, the distribution is displayed as missing.
c
Significantly different from 1; P < .05.
d
Significant difference between 2020 Q2 and 2019 Q2 SIRs; P < .05.